1. Introduction {#sec1}
===============

Keratoconus is a corneal ectasia which leads to progressive stromal thinning and protrusion, resulting in irregular astigmatism, visual impairment, and decreased quality of life, with a prevalence of approximately 1:2000, with varying susceptibilities in different ethnic groups.[@bib1] The progression of keratoconus occurs more intensely in the second and third decades of life and is more aggressive at puberty.[@bib2]^,^[@bib3] Its etiology is multifactorial, involving genetic and environmental factors.[@bib4]

Concerning corneal changes, increases in central epithelial thickness, breaks in Bowman\'s layer, and deformities of Descemet\'s are prevalent,[@bib5] as well as dramatic changes in collagen fibrils at the apex of the cone[@bib6] were previously described. In addition, many iris abnormalities have been described in keratoconus patients, such as lower tissue resistance during iridotomy,[@bib7] decreases in iris thickness,[@bib8] and iridoschisis.[@bib9]

Iris mammillations (IM) are described as multiple verrucous excrescences, or small elevations, distributed diffusely on the anterior iris surface bilaterally.[@bib10] They have been described previously as iris nodular nevi,[@bib11] or as a dotted Swiss iris,[@bib12] with a clear familial involvement.[@bib11], [@bib12], [@bib13] They are seen in association with various ocular conditions, such as ocular melanosis,[@bib10] oculodermal melanosis associated with uveal melanoma,[@bib14] congenital cataract, neurofibromatosis, congenital ptosis, and other similar ocular conditions.[@bib11] In addition, they have been associated with Cowden\'s syndrome[@bib11]^,^[@bib15] and congenital adrenal hyperplasia.[@bib13] The goal of this case series is to first describe patients who concomitantly present with keratoconus and IM.

2. Findings {#sec2}
===========

The study was approved by the local Ethics Committee and followed the tenets of the Declaration of Helsinki. A spontaneous and continuous observation of keratoconus patients with IM, who were currently under the care of a corneal ambulatory clinic in Hospital das Clínicas, Medical School of Ribeirão Preto, University of São Paulo, was recorded by a unique examiner (RAF). They were carefully examined with a slit lamp, and the following aspects of the iris of each patient were described: color, IM distribution along the iris surface, laterality, and the presence of iris nevi. Microscopic color photographs were taken at a 16X or 25X magnification. Corneal tomography images were obtained using the principle of Scheimpflug (Pentacam HR, Oculus Optikgeräte GmbH, Wetzlar, Germany). Best-corrected visual acuity (BCVA), mean (Km) and maximum keratometry (Kmax), medical history, family history of keratoconus, and corneal tomographic parameters were obtained from a review of their medical records. At least one of their eyes had not been surgically treated. A literature review was also undertaken.

[Case 1]{.ul}: A 14-year-old white girl ([Figs. 1--](#fig1){ref-type="fig"}), with best corrected visual acuity (BCVA) logMAR 0.5, mean keratometry (Km) 49.1, maximum keratometry (Kmax) 62.3 and thinnest pachymetry (Pachy) 457μm in the right eye (RE). She presented with iris nevi ([Figs. 1--](#fig1){ref-type="fig"}) and had a prior penetrating keratoplasty in the left eye (LE).Fig. 1Patients 1 to 8. The images were obtained during slit lamp microscopy and show diffusely distributed IM. White arrows indicate these structures in all photographs.Fig. 1

[Case 2]{.ul}: A 20-year-old white man ([Figs. 1--2](#fig1){ref-type="fig"}), with BCVA logMAR 0.4, Km 49.4, Kmax 60.3 and Pachy 428μm in the RE and BCVA logMAR \>1.0, Km 57.6, Kmax 65.4 and Pachy 385μm in the LE. He had a family history of keratoconus.

[Case 3]{.ul}: A 14-year-old mulatto boy ([Figs. 1--3](#fig1){ref-type="fig"}), with BCVA logMAR 0.2, Km 56.2, Kmax 69 and Pachy 393μm in the RE. His LE BCVA was logMAR 0.3, Km 51.2, Kmax 61.2 and Pachy 342μm. He presented with iris nevi and had a prior corneal cross-linking procedure in the LE.

[Case 4]{.ul}: A 14-year-old white girl ([Figs. 1--4](#fig1){ref-type="fig"}), whose BCVA on the RE was logMAR 0.9, Km 50.6, Kmax 54.8 and Pachy 513μm. The BCVA in the LE was logMar 0.0, Km 42.4, Kmax 46.3 and Pachy 579. She presented a pre-pupillary membrane and an iris shape that resembled iris atrophy ([Figs. 1--4](#fig1){ref-type="fig"}).

[Case 5]{.ul}: A 30-year-old white man ([Figs. 1--5](#fig1){ref-type="fig"}), who had a prior penetrating keratoplasty in the RE. His BCVA in the LE was logMAR 0.2, Km 51.7, Kmax 69.1 and Pachy 483μm.

[Case 6]{.ul}: A 11-year-old white boy ([Figs. 1--6](#fig1){ref-type="fig"}), with BCVA logMAR 0.4, Km 50.4, Kmax 63.0 and Pachy 477μm in the RE and BCVA logMAR 0.2, Km 50.6, Kmax 63.8 and Pachy 482μm in the LE. He had previous history of ocular atopy and blepharitis and a prior corneal cross-linking procedure in the RE.

[Case 7]{.ul}: A 12-year-old japanese boy ([Figs. 1--7](#fig1){ref-type="fig"}), with BCVA logMAR 0.1, Km 46.5, Kmax 49.5 and Pachy 537. The LE BCVA was logMAR 0.4, Km 60.3, Kmax 75.1 and Pachy 412μm.

[Case 8]{.ul}: A 18-year-old black woman ([Figs. 1--8](#fig1){ref-type="fig"}), with a prior penetrating keratoplasty in the RE. Her LE had a BCVA of 0.2, Km 69.2, Kmax 81.4 and Pachy 341μm. She was a rigid contact lenses user.

All of the patients had brown colored irises and bilateral IM, which appeared to be more visible in the upper half of the iris. Seven patients, except for patient 3, had diffusely but relatively uniformly distributed IM. Patient 3 had sparse and more pigmented IM ([Figs. 1--3](#fig1){ref-type="fig"}). Fundoscopy was unremarkable in all patients.

3. Discussion {#sec3}
=============

To the best of our knowledge, this is the first description of IM in keratoconus patients. Six out of 8 are pediatric patients, and 3 out of 8 had a penetrating keratoplasty, suggesting that these patients have a more aggressive form of the disease.

The etiology of IM and their clinical implications are not clear. As in keratoconus, they can occur sporadically or in familial cases.[@bib11]^,^[@bib13] The differential diagnosis of IM include all conditions which present with superficial elevations or iris irregularities, such as neurofibromatosis type 1, in which Lisch nodules[@bib16]^,^[@bib17] are observed, melanoma Tapioca, a rare tumor[@bib18] that may present as single or multiple lightly pigmented nodules in the iris, and Cogan-Reese syndrome that presents with iris nevus.[@bib19] The differential diagnosis[@bib20], [@bib21], [@bib22] of IM are displayed in [Table 1](#tbl1){ref-type="table"}.Table 1Differential diagnosis of iris mammillations.Table 1Morphology/LocalizationClinical featuresIris mammilationsMultiple verrucous excrescences, or small elevations, distributed diffusely on the anterior iris surface.\
Usually bilateral.May be associated with anterior segment malformation.Lisch nodulesFluffy texture. Brown colored in blue or green iris and pale in brown iris. Irregularly placed.Systemic stigmata of neurofibromatosis (cutaneous and central nervous system lesions).Granulomatous iridocyclitisNodules features are widely variable, differing among etiologies (sarcoidosis, infectious, Fuchs\'iridocyclitis).Anterior chamber cells, flare, and hypopyon. Iris dyscoria and posterior uveitis may be present.Juvenile xanthogranulomaNodular, well-circumscribed, thickened, orange-colored mass.\
Diffuse: thin coating or film, blunting the normal iris crypts. Unilateral.Presentation in early childhood. Iritis, hyphema, secondary glaucoma, neovascularization. May present characteristic skin lesions.Coogan Reese syndromePigmented, pedunculated nodules surrounded by flat iris stroma, loss of the normal iris architecture.\
Unilateral.Peripheral anterior synechiae, dyscoria, iris atrophy and glaucoma.Iris solid tumorsTapioca melanomaLightly pigmented multiple nodules or irregular large single nodules. Randomly situated (multiple) or inferior situated (single).Rare (1% of melanocytic iris tumors). Slow grow pattern. Glaucoma in 1/3 of patients.MelanomaUsually in inferior quadrant.Rare (4% of uveal melanoma). Primarily in the Caucasian population.NevusUsually in inferior quadrant.Most frequent (60%) melanocytic iris tumor). Low risk for growth into melanoma.Iris cystPrimarySingle or multiple. Regular borders, smooth surface, thin wall, clear fluid content. Usually unilateral (90%), at mid zonal iris (adults) and pupillary margin (children).Largely asymptomatic, non-progressive. Unusual.SecondaryUsually solitary, thick walls, irregular borders and surface, distortion of iris architecture. Unilateral, any local in iris surface.History of trauma, surgery, inflammation. Extension occurs over cornea, iris and lens. Iris bombé, secondary glaucoma, iritis, complicated cataracts.

Iris mammillations also have been described in association with other ocular disorders such as bilateral congenital cataract, oculodermal melanocytosis, congenital ptosis, Axenfeld and Peters anomaly.[@bib11] Similarly, other ocular disorders were already associated with keratoconus, such as posterior polymorphous dystrophy with iris heterochromia and band keratopathy,[@bib23] nanophthalmos and pigmentary retinopathy,[@bib24] and was also seen in a patient with Noonan syndrome.[@bib25] It is interesting that both keratoconus and IM were already associated with anterior segment abnormalities.[@bib11]^,^[@bib23]^,^[@bib24] The presence of IM and other different iris features, such as iris atrophy, associated with other signs of anterior segment malformations, may reinforce the idea that there may be a common genetic pathway which explains both alterations, probably based on extracellular matrix proteins fragility.

Future studies are needed to look for a correlation between keratoconus and IM, as well as other iris abnormalities that may not have been observed during routine examination. This may help to understand the natural history, prognosis, various etiologies, and known conditions associated with keratoconus.
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